Quick verdict: AEHR vs AOSL in 2026

Overall, Alpha and Omega Semiconductor Limited (AOSL) appears to have a stronger financial standing and more positive outlook compared to Aehr Test Systems (AEHR) in 2026. AOSL emerges as the clear growth leader with positive revenue expansion, and also presents a more compelling profile for value investors with significantly lower P/B and a less negative P/E ratio. Furthermore, AOSL holds the edge in profitability, demonstrating considerably better margin performance and is the preferred choice among analysts, indicating more potential upside. Not investment advice.

AEHR vs AOSL: key metrics side by side

Full side-by-side comparison of AEHR and AOSL across valuation, profitability, growth and analyst sentiment. Data updated 2026-05-08.

AEHR vs AOSL valuation comparison

Comparing the AEHR vs AOSL valuation metrics reveals a stark difference in how the market assesses these two technology stocks. Aehr Test Systems (AEHR) currently trades at a P/E ratio of -245.38x, reflecting significant unprofitability relative to its stock price. Its Price-to-Book (P/B) ratio stands at a high 20.18x, suggesting that investors are paying a substantial premium for its assets. The Discounted Cash Flow (DCF) analysis for AEHR indicates a valuation of $-1.51, representing a steep -101.7% downside from its current price, further highlighting potential overvaluation from a fundamental perspective.

In contrast, Alpha and Omega Semiconductor Limited (AOSL) presents a more favorable valuation picture despite also being unprofitable. AOSL’s P/E ratio is -14.52x, which, while negative, is considerably less severe than AEHR’s. Its P/B ratio is a much more conservative 1.4x, suggesting a significantly cheaper entry point relative to its book value. The DCF model for AOSL estimates a value of $6.92, indicating an -81.5% downside. While still suggesting overvaluation, this is a less drastic negative outlook than AEHR’s. Based on these metrics, AOSL appears to offer a more appealing AEHR vs AOSL valuation, with a lower P/B and a less extreme P/E and DCF-implied downside, positioning it as potentially the more “value” oriented choice between the two.

AEHR vs AOSL growth comparison

When assessing the AEHR vs AOSL growth comparison, Alpha and Omega Semiconductor Limited (AOSL) demonstrates a clear advantage in terms of top-line expansion. AOSL recorded a positive revenue growth of +5.9% year-over-year, alongside a substantial total revenue of $696,162,000. This indicates a company that is not only growing its sales but also operating on a significantly larger scale than its counterpart. This positive momentum suggests that AOSL is effectively capturing market opportunities and expanding its operational footprint within the semiconductor industry.

Conversely, Aehr Test Systems (AEHR) faced challenges, showing a revenue decline of -10.9% year-over-year, with total revenue at $58,968,000. This contraction in sales suggests headwinds or a downturn in demand for AEHR’s products and services, indicating a negative growth trajectory. The stark difference in revenue growth figures between AOSL and AEHR positions AOSL as the company with stronger momentum. Investors prioritizing top-line growth and market expansion would likely find AOSL’s performance more attractive, signaling its ability to increase its market presence and potentially drive future earnings.

AEHR vs AOSL profitability

A deep dive into the AEHR vs AOSL profitability metrics reveals both companies currently operate at a loss, but with varying degrees of financial health. Aehr Test Systems (AEHR) shows a net margin of -25.23% and an EBITDA margin of -29.97%. These significantly negative margins indicate that AEHR is incurring substantial losses relative to its revenue, struggling with operational costs and overall efficiency. The Return on Equity (ROE) for AEHR is N/A%, suggesting either negative equity or data unavailability which further complicates a clear profitability assessment.

Alpha and Omega Semiconductor Limited (AOSL), while also unprofitable, exhibits considerably better margin performance. AOSL reported a net margin of -11.25% and an EBITDA margin of -3.41%. These figures, while still negative, are substantially less so than AEHR’s, indicating a greater ability to control costs and move closer to profitability. Like AEHR, AOSL also has an ROE of N/A%. Regarding cash generation, AEHR’s Free Cash Flow (FCF) yield is -0.4%, which is less negative than AOSL’s -2.09%. While AEHR technically has a “better” (less negative) FCF yield, AOSL’s superior operational margins across net and EBITDA suggest a more fundamentally sound business model and a clearer path to positive profitability in the long run, even if its current FCF yield is lower. Therefore, AOSL generates more cash relative to its higher revenue and is operationally more efficient.

Analyst ratings: AEHR vs AOSL

The analyst ratings for AEHR vs AOSL provide valuable insights into market sentiment and expectations for these two semiconductor-related companies. Aehr Test Systems (AEHR) is covered by a smaller group of analysts, with only 3 providing ratings. Of these, 33.3% recommend a “Buy,” while the overall consensus stands at “Hold.” The average price target set by these analysts is $62, which represents a significant -32.1% downside from its current trading price. This indicates that the analyst community, on balance, sees limited upside potential and a degree of risk at AEHR’s current valuation.

In contrast, Alpha and Omega Semiconductor Limited (AOSL) garners significantly more attention from the analyst community, with 11 analysts covering the stock. A more substantial portion, 45.5%, recommend a “Buy,” contributing to a consensus rating of “Buy” for AOSL. The average price target for AOSL is $43, implying a positive upside of +14.9% from its current price. This stronger buy rating percentage, higher number of covering analysts, and a positive price target upside suggest that analysts have a more favorable view of AOSL’s prospects and potential for appreciation compared to AEHR.

Should I buy AEHR or AOSL stock in 2026?

When considering “should I buy AEHR or AOSL stock in 2026,” growth investors might find Alpha and Omega Semiconductor Limited (AOSL) to be the more compelling option. AOSL has demonstrated a positive revenue growth of +5.9% year-over-year, indicating an expanding business. This contrasts sharply with Aehr Test Systems (AEHR), which reported a revenue decline of -10.9%. For investors prioritizing companies with current growth momentum and a larger revenue base ($696,162,000 for AOSL vs $58,968,000 for AEHR), AOSL clearly holds the advantage.

For value investors, the “aehr vs aosl fundamentals and valuation” comparison points towards AOSL as the potentially cheaper stock. AOSL trades at a P/B ratio of 1.4x, which is significantly lower than AEHR’s 20.18x. While both companies are currently unprofitable, AOSL’s P/E of -14.52x is much less severe than AEHR’s -245.38x, suggesting its losses are more contained relative to its market capitalization. Furthermore, AOSL’s DCF upside of -81.5% is less negative than AEHR’s -101.7%. These metrics suggest that AOSL offers a more reasonable entry point and a less stretched valuation.

Regarding income generation, neither AEHR nor AOSL is suitable for investors seeking dividends. Both companies currently have a dividend yield of 0%, indicating they are reinvesting earnings back into the business or are not yet at a stage to distribute profits to shareholders. Therefore, for those focused on regular income from their investments, neither of these stocks would be a suitable choice. Ultimately, the decision to buy AEHR or AOSL in 2026 depends heavily on an investor’s risk tolerance and investment goals, with AOSL generally presenting a stronger overall financial and analyst outlook based on the provided data. This is not investment advice.

More AEHR and AOSL comparisons

AEHR full stock analysis · AOSL full stock analysis · All stock comparisons

FAQ: AEHR vs AOSL